Wegovy® for Weight Loss (Pen & Pill)
The FDA-approved brand-name semaglutide manufactured by Novo Nordisk. Available as both a once-weekly injection and a once-daily pill, prescribed online or in-person by our licensed providers.
- Lose ~15% of body weight on average over 68 weeks (STEP 1 trial data)
- Choose between weekly injection or once-daily pill, both FDA-approved
- Prescribed and monitored by our medical team from consultation to maintenance
What Is Wegovy®?
Wegovy® is the FDA-approved brand-name version of semaglutide manufactured by Novo Nordisk, dosed at 2.4mg weekly (injection) or 25mg daily (pill). In the STEP 1 clinical trial, patients lost an average of 14.9% of body weight over 68 weeks, the strongest clinical efficacy data for any single-mechanism GLP-1 weight loss medication.
Wegovy® uses the same active ingredient as Ozempic® but is approved at a higher dose specifically for weight management. To compare against tirzepatide-based options or other delivery formats, explore all FDA-approved GLP-1 options including Ozempic®, Zepbound®, and Mounjaro®.
Book Free Consultation
How Wegovy® Is Taken
Both forms contain semaglutide. The right choice depends on your lifestyle, travel patterns, and dosing preference.
| Factor | Wegovy® Pen (Injectable) | Wegovy® Pill (Oral) |
|---|---|---|
| Schedule | Weekly | Daily |
| Starting dose | 0.25 mg/week | 1.5 mg/day |
| Maintenance dose | 2.4 mg/week | 25 mg/day |
| Avg weight loss | ~15% | ~14–17% |
| Refrigeration | Required | Not required |
| Special instructions | None | 30-min wait before eating; 4oz water |
| FDA approved | 2021 | December 2025 |
| Travel friendly | Moderate (cooler needed) | High (room temp) |
What’s Included With Wegovy®
Real clinical oversight from intake to maintenance. Every Wegovy® program includes provider-led titration, ongoing safety monitoring, and direct access to your medical team.
Dr. Ashar N.
Dr. Ashar holds a Doctor of Nursing Practice and two national board certifications, one in family practice and one in psychiatric mental health.
She founded Tactus Health to close the gap she watched her own family fall through: symptoms that were real, labs that came back normal, and no one willing to connect the two.
She is responsible for the protocols our medical team follows, and for the training of the clinicians who deliver them. Holding both certifications is why those protocols treat hormones, mood, sleep and metabolism as one system rather than five separate appointments.
Cost of Wegovy®
With new manufacturer savings programs and discount platforms now available, Wegovy® has become more accessible than ever, but choosing the right path still depends on your individual situation.
The lowest price isn’t always the best outcome. Choosing the right pathway, and using it correctly, is what drives long-term results.
Already have access to Wegovy®? Our providers can still oversee your treatment and help optimize your results.
Access to medication is only one part of the process. Using the correct dose, managing side effects, and staying consistent over time is what ultimately determines results.
Wegovy® FAQ
Same active ingredient (semaglutide), different FDA approvals and doses. Ozempic® is approved for type 2 diabetes at up to 2.0mg weekly. Wegovy® is approved for chronic weight management at the higher 2.4mg dose, which produces greater weight loss. Read more about Ozempic® for weight loss.
Both forms are FDA-approved and produce comparable weight loss in clinical trials. The pen is once-weekly and requires refrigeration. The pill is once-daily, room-temperature stable, and ideal for travel, but requires a 30-minute wait before eating with no more than 4oz of water. Your provider will help you choose at your consultation.
Yes. Tactus Health is a direct-pay practice with transparent program pricing, no hidden fees, and no membership traps. HSA, FSA, Cherry, and CareCredit are accepted. Your provider will discuss program options and pricing during your free consultation.
Most commonly reported during dose escalation:
- Nausea
- Constipation
- Vomiting
- Diarrhea
- Stomach pain
These typically improve as your body adjusts. See full semaglutide safety information for serious risks and contraindications.
Wegovy® (semaglutide) and other GLP-1 medications may cause thyroid C-cell tumors. Do not use if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Common side effects include nausea, diarrhea, vomiting, and constipation. Not recommended during pregnancy or breastfeeding. Individual results vary. Read full semaglutide safety information → · Official Wegovy® ISI
Start Your Wegovy® Program
Free consultation with our licensed providers. We’ll review your clinical profile, health history, and available access pathways to recommend the right form, pen or pill, for your situation.